Sandbox Reserved 432
From Proteopedia
(→Overall Structure) |
(→Introduction) |
||
| Line 13: | Line 13: | ||
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
<scene name='48/483889/Structure/2'>TextToBeDisplayed</scene> | <scene name='48/483889/Structure/2'>TextToBeDisplayed</scene> | ||
| + | |||
| + | Background | ||
| + | -types of cancer it is used to treat | ||
| + | -How it works-Inhibits ALK (kinase) | ||
| + | -insert green scene of protein bound to ligand, linking on the word Inhibits | ||
| + | -or possible green scene on ALK kinase itself | ||
| + | - | ||
==Overall Structure== | ==Overall Structure== | ||
Revision as of 06:32, 24 February 2016
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
Contents |
Protein complex with cancer drug Alecensa-Alectinib (4uxl)
by Laura Feeley, Katie Kwan, Daniel Peters, Ishtiaq Rafiyu, Luke Ruksnaitis
Student Projects for UMass Chemistry 423 Spring 2016
Introduction
|
This is a sample scene created with SAT to by Group, and another to make of the protein.
Background -types of cancer it is used to treat -How it works-Inhibits ALK (kinase) -insert green scene of protein bound to ligand, linking on the word Inhibits -or possible green scene on ALK kinase itself -
Overall Structure
|
Binding Interactions
|
Additional Features
|
Quiz Question 1
|
See Also
[Structure of Human ROS1 Kinase Domain in Complex]
Credits
Introduction - name of team member
Overall Structure - name of team member
Drug Binding Site - name of team member
Additional Features - name of team member
Quiz Question 1 - name of team member
